{"title":"Towards a name change of schizophrenia: is it really necessary?","authors":"Lorenzo Pelizza, Simona Pupo","doi":"10.1007/s00406-025-02105-w","DOIUrl":"https://doi.org/10.1007/s00406-025-02105-w","url":null,"abstract":"","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hyperhomocysteinemia in chronic schizophrenia: prevalence, clinical correlates, and paradoxical associations with symptom severity.","authors":"Jianyan Du, Rui Jiang, Yuanyuan Liu, Jianan Zhou, Guoshuai Luo, Xiangyang Zhang","doi":"10.1007/s00406-025-02106-9","DOIUrl":"https://doi.org/10.1007/s00406-025-02106-9","url":null,"abstract":"<p><strong>Background: </strong>Elevated homocysteine levels, known as hyperhomocysteinemia (HHcy), have been implicated in the pathophysiology of schizophrenia. Most prior studies focused on first-episode or acute-phase schizophrenia patients, leaving the prevalence, determinants, and clinical correlates of HHcy in chronic schizophrenia understudied. This study aims to investigate the prevalence and determinants of HHcy in patients with chronic schizophrenia, as well as its clinical correlates. METHODS: A cross-sectional study was conducted involving 509 patients diagnosed with chronic schizophrenia, recruited from multiple psychiatric hospitals in China. Demographic, clinical, and lifestyle data were collected through structured interviews and medical record reviews. Blood samples were analyzed for homocysteine levels and other biochemical parameters. The Positive and Negative Syndrome Scale (PANSS), Hamilton Depression Rating Scale (HAMD), Insomnia Severity Index (ISI), and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) were used to assess clinical symptoms and cognitive function. Binary logistic regression analysis was performed to identify independent predictors of HHcy. RESULTS: The prevalence of HHcy in the study population was 56.2%. Patients with HHcy were significantly older (mean age: 52.1 ± 12.2 years) and had a higher proportion of males (67.1%) compared to those without HHcy. The HHcy group exhibited milder positive and general psychopathology symptoms, as indicated by lower PANSS scores, revealing unexpected inverse associations with symptom severity. Elevated levels of C-reactive protein (CRP), total bilirubin (TBIL), and creatine phosphokinase (CPK) were observed in the HHcy group. Binary logistic regression analysis identified female gender and older age as independent predictors of HHcy.</p><p><strong>Conclusions: </strong>This study highlights a high prevalence of HHcy in patients with chronic schizophrenia, associated with older age and male gender. Contrary to expectations, HHcy was linked to milder symptom severity, suggesting a potential paradoxical relationship.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vladislav Yakimov, Lara Neuwinger, Madeleine M Weber, Maximilian Brantl, Isabel Maurus, Jana Sautner, Miriam John, Berkhan Karslı, Genc Hasanaj, Anne Bungard, Alkomiet Hasan, Elias Wagner, Laura Fischer, Paula Steiner, Benedikt Schworm, Siegfried Priglinger, Sergi Papiol, Peter Falkai, Andrea Schmitt, Florian J Raabe, Daniel Keeser, Lukas Roell, Joanna Moussiopoulou, Emanuel Boudriot
{"title":"Clinical deep phenotyping of treatment response in schizophrenia (CDP-STAR): design and methodology of a prospective multimodal observational study.","authors":"Vladislav Yakimov, Lara Neuwinger, Madeleine M Weber, Maximilian Brantl, Isabel Maurus, Jana Sautner, Miriam John, Berkhan Karslı, Genc Hasanaj, Anne Bungard, Alkomiet Hasan, Elias Wagner, Laura Fischer, Paula Steiner, Benedikt Schworm, Siegfried Priglinger, Sergi Papiol, Peter Falkai, Andrea Schmitt, Florian J Raabe, Daniel Keeser, Lukas Roell, Joanna Moussiopoulou, Emanuel Boudriot","doi":"10.1007/s00406-025-02100-1","DOIUrl":"https://doi.org/10.1007/s00406-025-02100-1","url":null,"abstract":"","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145023029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Philipp Mench, T Koppius, J Ewen, W Rippe, J O Radecke, B Tari, M Heath, S Borgwardt, B Wilms, A Sprenger, R Lencer
{"title":"Cognitive control in schizophrenia spectrum disorders is associated with long-term movement activity rather than single-bout exercise.","authors":"Philipp Mench, T Koppius, J Ewen, W Rippe, J O Radecke, B Tari, M Heath, S Borgwardt, B Wilms, A Sprenger, R Lencer","doi":"10.1007/s00406-025-02101-0","DOIUrl":"https://doi.org/10.1007/s00406-025-02101-0","url":null,"abstract":"<p><strong>Background: </strong>Patients with schizophrenia spectrum disorder (SSD) suffer from impaired cognitive functions. Previous studies in healthy individuals have shown that a single bout of physical exercise benefits cognitive functions. Such enhancements in cognitive function would be highly beneficial, particularly for patients with SSD, as cognitive abilities play a vital role in both mental and physical health.</p><p><strong>Methods: </strong>We examined the impact of a single bout of aerobic exercise on cognitive function in 25 patients with SSD and 24 healthy controls. Participants performed a single bout of aerobic exercise adjusted to their individual fitness level. Cognitive function was examined pre- and postexercise via oculomotor tasks consisting of saccadic (i.e., pro- and antisaccades) and smooth pursuit eye movements (SPEM). Furthermore, long-term physical fitness and movement activity were assessed through an anaerobic threshold testing and self-reports of physical activity.</p><p><strong>Results: </strong>As expected, SSD-patients showed higher antisaccade error rates and were impaired in both SPEM initiation and maintenance with higher disorganization levels being related to lower SPEM performance. Neither the patient nor control group benefited from a single bout of exercise in terms of improved saccade or SPEM performance. However, higher fitness levels and more extensive long-term movement activity were associated with lower antisaccade error rates in patients.</p><p><strong>Conclusion: </strong>These findings do not demonstrate a single bout postexercise benefit in cognition; however, results indicate an association between greater cognitive control and long-term movement activity and thus underscore the importance of conducting further investigations into long-term exercise interventions as a complementary therapeutic approach.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaoying Dong, Tina Gupta, Gretchen Haas, Kristen L Eckstrand, Jennifer S Silk, Neal D Ryan, Erika E Forbes
{"title":"Psychotic-like experiences in adolescents enriched for high-risk for developing severe mental illness: change over two-years and associations with neural reward processing and affective symptoms.","authors":"Xiaoying Dong, Tina Gupta, Gretchen Haas, Kristen L Eckstrand, Jennifer S Silk, Neal D Ryan, Erika E Forbes","doi":"10.1007/s00406-025-02095-9","DOIUrl":"https://doi.org/10.1007/s00406-025-02095-9","url":null,"abstract":"<p><p>Psychotic-like experiences (PLEs) -subclinical experiences or symptoms that resemble psychosis, such as hallucinations and delusional thoughts-often emerge during adolescence and are predictive of serious psychopathology. Understanding PLEs during adolescence is crucial due to co-occurring developmental changes in neural reward systems that heighten the risk for psychotic-related and affective psychopathology, especially in those with a family history of severe mental illness (SMI). We examined associations among PLEs, clinical symptoms, and neural reward function during this critical developmental period. Over two-years, 117 adolescents (aged 13-19 years at baseline) at high-risk (n = 74) or low-risk (n = 43) for SMI based on family history of affective or psychotic disorder completed symptom questionnaires annually and fMRI scanning at study entry during a guessing reward task. We assessed changes in PLEs over two-years and evaluated whether clinical symptoms (anxiety, depression, anhedonia) and response to rewards of the dorsal medial prefrontal cortex (dmPFC) and ventral striatum (VS) predicted PLEs two-years later. PLEs total scores and distress increased over time, with the high-risk group showing a greater rise in PLEs than the low-risk group. Heightened right VS neural activation and higher anxiety at baseline (but not left VS or dmPFC neural activation, depression, or anhedonia) predicted more PLEs at 24-months. Heightened vigilance and sensitivity to external stimuli may be important precursors to the development of PLEs for adolescents.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145006016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thomas Bastelica, Karoline Huth, Maarten Marsman, Louis-Ferdinand Lespine, Guillaume Barbalat, Julien Plasse, Isabelle Chéreau-Boudet, Benjamin Gouache, Emilie Legros-Lafarge, Catherine Massoubre, Nathalie Guillard-Bouhet, Frédéric Haesebaert, Thierry d'Amato, Nicolas Franck, Romain Rey
{"title":"Exploring interrelationships between cognition, functioning and quality of life in schizophrenia spectrum disorders: a Bayesian analysis of networks.","authors":"Thomas Bastelica, Karoline Huth, Maarten Marsman, Louis-Ferdinand Lespine, Guillaume Barbalat, Julien Plasse, Isabelle Chéreau-Boudet, Benjamin Gouache, Emilie Legros-Lafarge, Catherine Massoubre, Nathalie Guillard-Bouhet, Frédéric Haesebaert, Thierry d'Amato, Nicolas Franck, Romain Rey","doi":"10.1007/s00406-025-02084-y","DOIUrl":"https://doi.org/10.1007/s00406-025-02084-y","url":null,"abstract":"","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144991816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Association between high-density lipoprotein-related inflammation index and prevalence of sleep disorders with depression as a mediator.","authors":"Shuo Gao, Pu-Le Liu, Qiang-Li Dong, Xin-Ru Liu, Zhi-Qiang Dong, Ya-Wen Pan","doi":"10.1007/s00406-025-02099-5","DOIUrl":"10.1007/s00406-025-02099-5","url":null,"abstract":"<p><strong>Background: </strong>Sleep disorders have a significant impact on physical health, mental health, and daily functioning, exacerbated by the accelerating pace of life and rising work-related stress in contemporary society. The incidence of sleep disorders continues to rise annually, becoming a significant global public health issue. The white blood cell-to-HDL-cholesterol ratio (WHR), lymphocyte-to-HDL-cholesterol ratio (LHR), monocyte-to-HDL-cholesterol ratio (MHR), neutrophil-to-HDL-cholesterol ratio (NHR), and platelet-to-HDL-cholesterol ratio (PHR) are emerging, convenient, and cost-effective biomarkers that reflect systemic inflammation and immunometabolic status. Given the growing evidence linking chronic inflammation and dysregulated immune responses to prevalence of sleep disorders, exploring the association between these hematologic-lipid ratios and prevalence of sleep disorders may provide novel insights into underlying pathophysiological mechanisms.</p><p><strong>Methods: </strong>The study included a diverse and extensive sample of 43,273 participants, selected from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and March 2020. The association between HDL- associated inflammatory biomarkers and prevalence of sleep disorders was explored using a multivariate logistic regression model with weighted analysis. In addition, the mediating role of depression levels (PHQ-9) between HDL-associated inflammatory markers and prevalence of sleep disorders was examined.</p><p><strong>Results: </strong>This study suggests that higher levels of MHR and PHR were associated with an increased risk of sleep disorders, with a more pronounced association observed for MHR among male smokers and individuals with comorbidities, and for PHR among males and those with comorbidities. Mediation analysis demonstrates that depression level (PHQ-9) plays a significant mediating role between prevalence of sleep disorders and MHR or PHR.</p><p><strong>Conclusion: </strong>Elevated MHR and PHR levels were significantly associated with an increased risk of sleep disorders. The association of MHR was particularly pronounced among male smokers and individuals with comorbidities, while PHR showed stronger associations in males and those with comorbidities. Depression levels partially mediated these associations. MHR and PHR may serve as clinically useful biomarkers for identifying high-risk individuals, supporting the need for early screening and intervention. Future longitudinal studies are warranted to confirm causality and assess whether targeting these indices can improve sleep outcomes.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Serum ZO-1 and occludin levels in bipolar disorder patients.","authors":"Pınar Aydogan Avşar, Merve Akkuş","doi":"10.1007/s00406-025-02097-7","DOIUrl":"https://doi.org/10.1007/s00406-025-02097-7","url":null,"abstract":"<p><p>Bipolar disorder is a mental illness with a complex and multidimensional etiology. The blood-brain barrier (BBB) is a semi-permeable barrier between the central nervous system (CNS) and peripheral circulation that protects the CNS from external threats. The healthy functioning of the BBB is ensured by tight junctions (TJs) between cells. This research aims to investigate the serum levels of TJ proteins occludin and zonula occludens-1 protein (ZO-1) in bipolar disorder to elucidate etiopathogenesis. This study included 40 BD patients (20 manic episodes, 20 euthymic episodes) and 40 healthy controls. Serum occludin and ZO-1 values were obtained and compared between the two groups. The serum occludin and ZO-1 levels were significantly higher in the bipolar disorder patients. The analysis of covariance (ANCOVA) revealed a significant main effect of groups in the serum occludin and ZO-1 levels and an effect that was independent of age, gender, BMI, and smoking.BBB disruption and neuroinflammation may play a role in bipolar disorder etiopathogenesis. Occludin and ZO-1 may serve as potential biomarkers for BBB leakage in bipolar disorder. Further research may lead to additional pharmacological therapies targeting BBB for drug-resistant bipolar disorder patients.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The association between maladaptive daydreaming and eating and obsessive-compulsive disorders in the general population: the mediating role of alexithymia.","authors":"Alessia Renzi, Bleona Bytyqi, Rachele Mariani","doi":"10.1007/s00406-025-02083-z","DOIUrl":"https://doi.org/10.1007/s00406-025-02083-z","url":null,"abstract":"<p><p>Maladaptive daydreaming (MD) is a recently defined clinical condition characterized by an excessively immersive utilization of fantasy and imagination which can significantly impact both professional and social life. International literature has linked MD to obsessive-compulsive symptoms, but its association with alexithymia remains largely unexplored, and its connection to eating disorder symptoms is even more neglected. As a marker of affect regulation difficulties, alexithymia may heighten the risk and severity of MD, eating disorders, and obsessive-compulsive symptoms. Therefore, the general aim of the present study is to contribute to the study of MD in the general population, by examining potential associations between MD levels, eating disorders, obsessive-compulsive symptoms, and affect regulation capabilities. Additionally, the study aims to examine whether alexithymia mediates the relationship between eating and obsessive-compulsive symptoms, respectively, and MD levels. 562 participants (mean age = 27.16 years; SD = 10.21; 68% females) completed an online survey comprising: a socio-demographic questionnaire, the Maladaptive Daydreaming Scale (MDS), the 20-item Toronto Alexithymia Scale (TAS-20), the Eating Attitude Test (EAT-26), and the Obsessional Beliefs Questionnaire (OBQ-44). MDS score was positively related to TAS-20 total, difficulties in identifying and describing feelings as well as with eating disorders and obsessive-compulsive symptoms. Age showed a weak negative association with MDS. Regarding the mediation models, alexithymia significantly amplified the impact of eating/obsessive-compulsive symptoms on MD. The associations emerging by present study seem to support a common functioning of these clinical conditions based on maladaptive/compulsive behaviours/thought/fantasy, as strategy to regulate painful emotions. Further studies comparing these clinical populations are still needed.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lorenzo Pelizza, Andrea Berti, Alessandro Di Lisi, Michele La Maida, Emanuela Leuci, Emanuela Quattrone, Derna Palmisano, Simona Pupo, Giuseppina Paulillo, Clara Pellegrini, Pietro Pellegrini, Marco Menchetti
{"title":"Subjective language disturbances in young patients at ultra-high risk for psychosis (UHR): what relevance for clinical prognosis? A 2-year follow-up study.","authors":"Lorenzo Pelizza, Andrea Berti, Alessandro Di Lisi, Michele La Maida, Emanuela Leuci, Emanuela Quattrone, Derna Palmisano, Simona Pupo, Giuseppina Paulillo, Clara Pellegrini, Pietro Pellegrini, Marco Menchetti","doi":"10.1007/s00406-025-02094-w","DOIUrl":"https://doi.org/10.1007/s00406-025-02094-w","url":null,"abstract":"<p><strong>Introduction: </strong>Language impairment has the potential to predict the onset and progression of psychosis. However, it was mainly examined using automated extraction of quantitative linguistic features and their associations with observable psychopathological aspects of psychosis (e.g., formal thought disorders). Little interest has been paid to subjective language disturbances that should phenomenologically anticipate these more objective clinical features. Therefore, the aim of this examination was to investigate subjective language disorders in a Ultra-High Risk (UHR) sample and their associations with clinical and functional outcomes along 2 years of follow-up.</p><p><strong>Methods: </strong>170 UHR participants (88 [51.8%] females; mean age = 19.52 ± 6.03 years) were assessed for a broad range of clinical outcomes, including psychosis transition, clinical and functional remission measured with the Positive and Negative Syndrome Scale and the Social and Occupational Functioning Assessment Scale. Comparisons between patients with or without baseline subjective language disorders (specifically explored with the Schizophrenia Proneness Instrument) were analyzed using Chi-Square and Mann-Whitney tests, Kaplan-Meier survival analysis, and binary logistic regression analysis.</p><p><strong>Results: </strong>Across the follow-up, the UHR subgroup with language disorders at entry (n = 80) showed higher and more enduring severity in psychopathology (especially negative and disorganized features), as well as poorer socio-occupational functioning over time.</p><p><strong>Conclusion: </strong>The presence of subjective language disturbances at baseline identifies a subgroup of UHR youths with poorer psychopathological and functional prognosis. Further studies examining their association with quantitative linguistic biomarkers are needed, especially to better predict the onset and progression of psychosis.</p>","PeriodicalId":11822,"journal":{"name":"European Archives of Psychiatry and Clinical Neuroscience","volume":" ","pages":""},"PeriodicalIF":3.7,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144947442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}